Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Healthy volunteers

Filters:

Stenotic Coronary Lesion

Tundra lists 4 Stenotic Coronary Lesion clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT03466151

RESOLUTE ONYX China RCT Study

It is a randomized controlled trial to evaluate the safety and efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in comparison with the Medtronic Resolute Integrity™ Zotarolimus-Eluting coronary stent system in the treatment of subjects eligible for percutaneous transluminal coronary angioplasty (PTCA) in China.

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-21

1 state

Ischemic Heart Disease

Stenotic Coronary Lesion

Cardiovascular Diseases

COMPLETED

NCT03471845

RESOLUTE ONYX China Single Arm Study

It is a single arm clinical evaluation of safety and efficacy of the Medtronic Resolute Onyx™ zotarolimus-eluting coronary stent system in subjects who are eligible for percutaneous transluminal coronary angioplasty (PTCA) in de novo lesions amenable to treatment with Resolute Onyx™ Stent System in China.

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-21

1 state

Ischemic Heart Disease

Stenotic Coronary Lesion

Cardiovascular Diseases

RECRUITING

NCT07811024

First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to Treat Subjects Who Have Coronary Artery Disease (CAD) Involving In-Stent Restenosis (ISR) or an Unstented Lesion in a Small Coronary Vessel (DNSV).

The goal of this clinical trial is to learn if the SiroMax™ drug-coated balloon catheter is safe and works to treat stenotic coronary lesions in adults. Participants will be screened to determine if they meet the eligibility requirements for the study. Eligible participants who provide informed consent will receive treatment with the study device and be followed for 5 years.

Gender: All

Ages: 21 Years - Any

Updated: 2026-09-14

Coronary Artery Disease

Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

In-Stent Restenosis or De Novo Coronary Artery Lesions

+10

ACTIVE NOT RECRUITING

NCT06885177

TECTONIC CAD IVL IDE Study

A prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites

Gender: All